Work

Neratinib inhibits Hippo/YAP signaling, reduces mutant K-RAS expression, and kills pancreatic and blood cancer cells

Year: 2019

Type: article

Source: Oncogene

DOI: 10.1038/s41388-019-0849-8

Authors: Paul Dent, Laurence Booth, Jane L. Roberts, Junchen Liu, Andrew Poklepovic, Alshad S. Lalani, David Tuveson, Jennifer Martinez, John F. Hancock

Institutions: Virginia Commonwealth University, The University of Texas Health Science Center at Houston, Puma Biotechnology (United States), Cold Spring Harbor Laboratory, National Institute of Environmental Health Sciences

Language: English

Topic: Hippo pathway signaling and YAP/TAZ

Subfield: Cell Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute, National Institute of Environmental Health Sciences

Awards: G1122075389, Pemetrexed and sildenafil for lung cancer, Characterization of the molecular mechanisms of LC3-associated phagocytosis and its role in disease pathogenesis

OpenAlex ID: W2953798516

FWCI: 5.991

Cites: 51

Cited by: 79

Related to: 10